Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$67.91
-1.55-2.23%
al cierre: -
$67.78
-0.13-0.19%
After hour: 7:52 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Nutanix Inc ha un obiettivo di prezzo di consenso pari a $85.65, stabilito in base alle ultime valutazioni degli analisti di 20. Le ultime 3 valutazioni degli analisti sono state rilasciate da Goldman Sachs, Keybanc y Susquehanna il julio 15, 2025, junio 26, 2025 y mayo 29, 2025. Con un obiettivo di prezzo medio di $95 tra le Goldman Sachs, Keybanc y Susquehanna, c'è un implicito 40.16% upside per Nutanix Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Goldman Sachs
Keybanc
Susquehanna
Piper Sandler
Needham
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Nutanix
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
07/15/2025 | 40.16% | Goldman Sachs | → $95 | Initiates | → Buy | |||
06/26/2025 | 40.16% | Keybanc | → $95 | Initiates | → Overweight | |||
05/29/2025 | 40.16% | Susquehanna | $90 → $95 | Maintains | Positive | |||
05/29/2025 | 29.83% | Piper Sandler | $76 → $88 | Maintains | Overweight | |||
05/29/2025 | 35.73% | Needham | $92 → $92 | Reiterates | Buy → Buy | |||
05/20/2025 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
05/20/2025 | 32.78% | Morgan Stanley | $75 → $90 | Maintains | Overweight | |||
04/08/2025 | 10.65% | Morgan Stanley | $85 → $75 | Maintains | Overweight | |||
04/08/2025 | 12.13% | Piper Sandler | $88 → $76 | Maintains | Overweight | |||
02/28/2025 | 32.78% | Susquehanna | $85 → $90 | Maintains | Positive | |||
02/27/2025 | 22.46% | Raymond James | $76 → $83 | Maintains | Outperform | |||
02/27/2025 | 34.26% | UBS | $81 → $91 | Maintains | Buy | |||
02/27/2025 | 40.16% | RBC Capital | $83 → $95 | Maintains | Outperform | |||
02/27/2025 | 38.68% | Barclays | $87 → $94 | Maintains | Overweight | |||
02/27/2025 | 29.83% | Piper Sandler | $83 → $88 | Maintains | Overweight | |||
02/27/2025 | 47.54% | Oppenheimer | $90 → $100 | Maintains | Outperform | |||
02/27/2025 | 35.73% | Needham | $90 → $92 | Maintains | Buy | |||
02/27/2025 | 25.41% | Wells Fargo | $75 → $85 | Maintains | Equal-Weight | |||
02/27/2025 | 32.78% | JP Morgan | $83 → $90 | Maintains | Overweight | |||
01/17/2025 | 12.13% | Raymond James | $83 → $76 | Maintains | Outperform | |||
12/17/2024 | 25.41% | Morgan Stanley | $78 → $85 | Maintains | Overweight | |||
12/12/2024 | 19.5% | UBS | → $81 | Initiates | → Buy | |||
11/27/2024 | 10.65% | Wells Fargo | $60 → $75 | Maintains | Equal-Weight | |||
11/27/2024 | 22.46% | Piper Sandler | $77 → $83 | Maintains | Overweight | |||
11/27/2024 | 15.08% | Morgan Stanley | $72 → $78 | Maintains | Overweight | |||
11/27/2024 | 28.36% | Barclays | $75 → $87 | Maintains | Overweight | |||
11/27/2024 | 13.6% | Northland Capital Markets | $74 → $77 | Reiterates | Market Perform → Market Perform | |||
11/27/2024 | 32.78% | Needham | $80 → $90 | Maintains | Buy | |||
11/13/2024 | 18.03% | Oppenheimer | → $80 | Initiates | → Outperform | |||
10/28/2024 | 6.23% | Morgan Stanley | $71 → $72 | Upgrade | Equal-Weight → Overweight | |||
08/30/2024 | 9.18% | Northland Capital Markets | $71 → $74 | Maintains | Market Perform | |||
08/29/2024 | 10.65% | RBC Capital | $70 → $75 | Maintains | Outperform | |||
08/29/2024 | 13.6% | Piper Sandler | $76 → $77 | Maintains | Overweight | |||
08/29/2024 | 10.65% | JP Morgan | $65 → $75 | Maintains | Overweight | |||
08/29/2024 | 25.41% | Raymond James | $76 → $85 | Maintains | Outperform | |||
08/29/2024 | 10.65% | Barclays | $71 → $75 | Maintains | Overweight | |||
08/29/2024 | 4.75% | Morgan Stanley | $62 → $71 | Maintains | Equal-Weight | |||
08/29/2024 | 10.65% | B of A Securities | $72 → $75 | Maintains | Buy | |||
08/29/2024 | 18.03% | Needham | $80 → $80 | Reiterates | Buy → Buy | |||
08/23/2024 | -4.1% | JP Morgan | $80 → $65 | Maintains | Overweight | |||
08/21/2024 | 6.23% | B of A Securities | $75 → $72 | Maintains | Buy | |||
08/20/2024 | 4.75% | Barclays | $80 → $71 | Maintains | Overweight | |||
06/21/2024 | -8.53% | Morgan Stanley | $72 → $62 | Maintains | Equal-Weight | |||
05/30/2024 | 18.03% | Barclays | $81 → $80 | Maintains | Overweight | |||
05/30/2024 | 12.13% | Raymond James | $72 → $76 | Maintains | Outperform | |||
05/30/2024 | 18.03% | Needham | $72 → $80 | Maintains | Buy | |||
05/30/2024 | 16.55% | Keybanc | $69 → $79 | Maintains | Overweight | |||
05/24/2024 | 19.5% | Barclays | $68 → $81 | Maintains | Overweight | |||
05/24/2024 | 18.03% | JP Morgan | $70 → $80 | Maintains | Overweight | |||
05/23/2024 | 6.23% | Morgan Stanley | $63 → $72 | Maintains | Equal-Weight | |||
04/10/2024 | 10.65% | Susquehanna | $60 → $75 | Maintains | Positive | |||
03/27/2024 | -7.05% | Morgan Stanley | $58 → $63 | Maintains | Equal-Weight | |||
02/29/2024 | 1.8% | Keybanc | $68 → $69 | Maintains | Overweight | |||
02/29/2024 | 6.23% | RBC Capital | $68 → $72 | Maintains | Outperform | |||
02/29/2024 | 3.28% | JP Morgan | $65 → $70 | Maintains | Overweight | |||
02/29/2024 | -4.1% | B of A Securities | $55 → $65 | Maintains | Buy | |||
02/29/2024 | 12.13% | Piper Sandler | $67 → $76 | Maintains | Overweight | |||
02/29/2024 | 6.23% | Needham | $62 → $72 | Maintains | Buy | |||
02/29/2024 | 0.32% | Barclays | $49 → $68 | Maintains | Overweight | |||
02/26/2024 | -4.1% | JP Morgan | $54 → $65 | Maintains | Overweight | |||
02/09/2024 | 0.32% | Keybanc | $60 → $68 | Maintains | Overweight | |||
02/05/2024 | 3.28% | JMP Securities | $50 → $70 | Maintains | Market Outperform | |||
01/18/2024 | -11.48% | Keybanc | $51 → $60 | Maintains | Overweight | |||
01/17/2024 | -8.53% | Needham | $54 → $62 | Maintains | Buy | |||
01/17/2024 | — | William Blair | — | Upgrade | Market Perform → Outperform | |||
12/01/2023 | -11.48% | Susquehanna | $48 → $60 | Maintains | Positive | |||
11/30/2023 | -26.23% | JMP Securities | $45 → $50 | Maintains | Market Outperform | |||
11/30/2023 | -26.23% | Piper Sandler | $42 → $50 | Maintains | Overweight | |||
11/30/2023 | -26.23% | Morgan Stanley | $38 → $50 | Maintains | Equal-Weight | |||
11/30/2023 | -20.33% | RBC Capital | $47 → $54 | Maintains | Outperform | |||
11/30/2023 | -38.03% | Wells Fargo | $35 → $42 | Maintains | Equal-Weight | |||
11/30/2023 | -20.33% | Needham | $44 → $54 | Maintains | Buy | |||
09/27/2023 | -30.66% | RBC Capital | $43 → $47 | Maintains | Outperform | |||
09/27/2023 | -43.94% | Morgan Stanley | $36 → $38 | Maintains | Equal-Weight | |||
09/27/2023 | -38.03% | Piper Sandler | $40 → $42 | Maintains | Overweight | |||
09/27/2023 | -33.61% | JMP Securities | $35 → $45 | Maintains | Market Outperform | |||
09/27/2023 | -35.08% | Needham | → $44 | Reiterates | Buy → Buy | |||
09/27/2023 | -32.13% | Keybanc | $45 → $46 | Maintains | Overweight | |||
09/21/2023 | -26.23% | B of A Securities | $39 → $50 | Upgrade | Neutral → Buy | |||
09/01/2023 | -40.99% | Piper Sandler | $35 → $40 | Maintains | Overweight | |||
09/01/2023 | -33.61% | Northland Capital Markets | $39 → $45 | Maintains | Outperform | |||
09/01/2023 | -46.89% | Morgan Stanley | $32 → $36 | Maintains | Equal-Weight | |||
09/01/2023 | -36.56% | RBC Capital | $38 → $43 | Maintains | Outperform | |||
09/01/2023 | -36.56% | Barclays | $38 → $43 | Maintains | Overweight | |||
09/01/2023 | -48.36% | JMP Securities | → $35 | Reiterates | Market Outperform → Market Outperform | |||
09/01/2023 | -35.08% | Needham | $33 → $44 | Maintains | Buy | |||
09/01/2023 | -33.61% | Keybanc | $35 → $45 | Maintains | Overweight | |||
08/11/2023 | -48.36% | Keybanc | $38 → $35 | Maintains | Overweight | |||
05/26/2023 | -48.36% | Wells Fargo | $32 → $35 | Maintains | Equal-Weight | |||
05/25/2023 | -49.84% | B of A Securities | $31 → $34 | Maintains | Neutral | |||
05/25/2023 | -48.36% | Piper Sandler | $33 → $35 | Maintains | Overweight | |||
05/25/2023 | -43.94% | RBC Capital | $33 → $38 | Maintains | Outperform | |||
05/25/2023 | -42.46% | Northland Capital Markets | $34 → $39 | Maintains | Outperform | |||
05/25/2023 | -52.79% | Morgan Stanley | $30 → $32 | Maintains | Equal-Weight | |||
05/25/2023 | -51.31% | Needham | $33 → $33 | Reiterates | Buy → Buy | |||
05/25/2023 | -43.94% | Barclays | $34 → $38 | Maintains | Overweight | |||
05/25/2023 | -43.94% | Keybanc | $33 → $38 | Maintains | Overweight | |||
05/18/2023 | — | OTR Global | — | — | Downgrade | Positive → Mixed | ||
05/01/2023 | -48.36% | JMP Securities | → $35 | Reiterates | → Market Outperform | |||
03/09/2023 | -49.84% | Susquehanna | → $34 | Reiterates | → Positive |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Nutanix (NTNX)?
El último precio objetivo de Nutanix (NASDAQ:NTNX) fue comunicado por Goldman Sachs el julio 15, 2025. La firma de analistas fijó un precio objetivo para $95.00 que espera NTNX a rise dentro de 12 meses (un posible 40.16% upside). 41 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Nutanix (NTNX)?
La última calificación de analistas para Nutanix (NASDAQ:NTNX) fue proporcionada por Goldman Sachs, y Nutanix iniciado su buy calificación.
¿Cuándo se produjo la última revisión al alza de Nutanix (NTNX)?
La última revisión al alza de Nutanix Inc se produjo en octubre 28, 2024, cuando Morgan Stanley elevó su precio objetivo a $72. Morgan Stanley anteriormente tenía an equal-weight para Nutanix Inc.
¿Cuándo fue la última revisión a la baja de Nutanix (NTNX)?
La última revisión a la baja de Nutanix Inc se produjo en mayo 20, 2025, cuando Raymond James cambió su precio objetivo de N/A a N/A para Nutanix Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Nutanix (NTNX)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Nutanix, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Nutanix se registró el julio 15, 2025, por lo que la próxima calificación estará disponible en torno al julio 15, 2026.
¿Es correcta la calificación de los analistas sobre Nutanix (NTNX)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Nutanix (NTNX) fue un iniciado con un precio objetivo de $0.00 a $95.00. El precio actual al que cotiza Nutanix (NTNX) es de $67.78, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.